aTyr Pharma, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $6.2M | $104.8M | $8.3M |
| Jun 2022 | $9.4M | $96.0M | $8.5M |
| Sep 2022 | $18.9M | $96.1M | $18.4M |
| Dec 2022 | $24.3M | $95.8M | $10.0M |
| Mar 2023 | $27.0M | $136.8M | $20.7M |
| Jun 2023 | $26.5M | $132.7M | $12.3M |
| Sep 2023 | $26.7M | $125.1M | $9.8M |
| Dec 2023 | $30.0M | $120.7M | $22.5M |
| Mar 2024 | $28.8M | $113.3M | $6.8M |
| Jun 2024 | $24.3M | $105.9M | $6.8M |
| Sep 2024 | $26.3M | $91.6M | $11.5M |
| Dec 2024 | $26.8M | $96.8M | $11.1M |
| Mar 2025 | $22.2M | $97.2M | $10.4M |
| Jun 2025 | $26.7M | $101.5M | $17.2M |
| Sep 2025 | $26.4M | $106.7M | $6.2M |
| Dec 2025 | $25.5M | $93.0M | $10.7M |
| Mar 2026 | $21.7M | $79.7M | $10.0M |
| Jun 2026 | $21.0M | $69.8M | $16.2M |